Company Filing History:

25 out of 1,001

Shionogi Company Limited

patents

2 out of 25

Shionogi Seiyaku Kabushiki Kaisha

patents

1 out of 44

Teikoku Hormone Mfg. Co., Ltd.

patents

Years Active: 1978-2001

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE37314 - Pyrimidine derivatives (2001-08-07),

2. 5260440 - Pyrimidine derivatives (1993-11-09),

3. 5128366 - Pyrrole derivatives (1992-07-07),

4. 4977170 - Isoprenoidamine compounds which are useful antiulcer agents (1990-12-11),

5. 4900749 - Isoprenoidamine compounds useful as antiulcer agents (1990-02-13),

6. 4882338 - Substituted isoquinoline derivatives and anti-ulcer agents (1989-11-21),

7. 4839365 - Thienopyridine derivatives useful in treating gastric ulcers (1989-06-13),

8. 4564623 - Aminoalkylbenzene derivatives (1986-01-14),

9. 4492794 - 2-Guanidino-4-hydroxymethylthiazole and derivatives thereof (1985-01-08),

10. 4482566 - Substituted aminoalkylbenzene type lower acylamides (1984-11-13),

11. 4476133 - Triazolo-4,1-benzoxazepines having CNS activity (1984-10-09),

12. 4433154 - Bis(carboxamide) derivatives (1984-02-21),

13. 4374842 - 4,1-Benzoxazepines and compositions (1983-02-22),

14. 4341704 - 4,1-Benzoxazepines and thia analogs thereof (1982-07-27),

15. 4318858 - Thioethylamide derivatives (1982-03-09),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the requested article about inventor Kentaro Hirai.

Title: The Innovative Journey of Kentaro Hirai: Pioneering Treatments for Hypercholesterolemia

Introduction:

Kentaro Hirai, a distinguished inventor based in Kyoto, Japan, has left an indelible mark on the field of pharmaceuticals with his groundbreaking patents. With a total of 28 patents to his name, Hirai-san's contributions have revolutionized the treatment of conditions such as hypercholesterolemia, hyperlipoproteinemia, and atherosclerosis.

Latest Patents:

Hirai-san's most recent patents focus on pyrimidine derivatives that act to inhibit the HMG-CoA reductase enzyme, effectively reducing cholesterol biosynthesis. These compounds have shown remarkable efficacy in managing conditions related to cholesterol metabolism, offering new hope to patients worldwide.

Career Highlights:

Having worked for esteemed companies like Shionogi & Company Limited and Shionogi Seiyaku Kabushiki Kaisha, Kentaro Hirai has honed his skills and expertise in pharmaceutical research and development. His relentless pursuit of innovation has led to the successful filing of numerous patents that have the potential to transform healthcare practices.

Collaborations:

Throughout his career, Hirai-san has collaborated with notable peers such as Teruyuki Ishiba and Hirohiko Sugimoto. Together, they have pushed the boundaries of pharmaceutical science, paving the way for novel therapeutic interventions and improved patient outcomes.

Conclusion:

In conclusion, Kentaro Hirai stands as a shining example of an inventor whose dedication to innovation has reshaped the landscape of modern medicine. His invaluable contributions in the development of novel treatments for hypercholesterolemia underscore the importance of pioneering research in addressing healthcare challenges. Kentaro Hirai's legacy as a visionary inventor continues to inspire future generations in the pursuit of scientific excellence.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (CIPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.